VERKAZIA

This brand name is authorized in Austria, Canada, Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug VERKAZIA contains one active pharmaceutical ingredient (API):

1 Ciclosporin UNII 83HN0GTJ6D - CYCLOSPORINE

Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect. Read about Ciclosporin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VERKAZIA Eye drops, emulsion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01XA18	Ciclosporin	S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02484137
Country: EE	Ravimiamet	Identifier(s): 1775279, 1775280, 1775291, 1775303
Country: FR	Base de données publique des médicaments	Identifier(s): 66421434
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 358404
Country: IT	Agenzia del Farmaco	Identifier(s): 046918013, 046918025, 046918037, 046918049, 046918052
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085925, 1085926, 1085927, 1085928
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100416795